+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 1026987-94-9
1026987-94-9,MFCD28898588
Catalog No.:AA00082D

1026987-94-9 | L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$162.00   $114.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00082D
Chemical Name:
L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester
CAS Number:
1026987-94-9
Molecular Formula:
C23H40N2O9
Molecular Weight:
488.5717
MDL Number:
MFCD28898588
SMILES:
OC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)N[C@H](C(=O)OC(C)(C)C)CCC(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
743  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
16  
XLogP3:
2.3  

Downstream Synthesis Route

[1]JournalofDrugTargeting,2013,vol.21,p.968-980

[2]Patent:US2018/99934,2018,A1

[3]MolecularPharmaceutics,2018,vol.15,p.1842-1852

[4]AngewandteChemie-InternationalEdition,2018,vol.57,p.12733-12736    Angew.Chem.,2018,vol.130,p.12915-12918,4

[5]Patent:WO2019/57964,2019,A1

[1]Patent:WO2013/22797,2013,A1.Locationinpatent:Page/Pagecolumn69

[1]Patent:WO2015/69766,2015,A1.Locationinpatent:Paragraph00218

[1]Patent:WO2015/69766,2015,A1

H-cysteine(trityl)-2-chlorotritylresin 
  1026987-94-9    35661-40-6    71989-14-5    131570-56-4    126631-93-4    1025066-50-5 

[1]JournalofMedicinalChemistry,2015,vol.58,p.3094-3103

Literature

Title: Roy J, et al. DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selectiveprostate cancer cell targeting. J Med Chem. 2015 Apr 9;58(7):3094-103.

Title: Lv Q, et al. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate. Mol Pharm. 2018 May 7;15(5):1842-1852.

Title: Peng ZH, et al. Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specificmembrane antigen expressing prostate cancer. J Drug Target. 2013 Dec;21(10):968-80.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1026987-94-9
1025796-31-9

1025796-31-9
Building Blocks
More >
Tags:1026987-94-9 Molecular Formula|1026987-94-9 MDL|1026987-94-9 SMILES|1026987-94-9 L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester